Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 24, Issue 10

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 24, Issue 10 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 24, Issue 10 (2015)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Volume 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Review

Early investigational β3 adreno-receptor agonists for the management of the overactive bladder syndrome

Ganesh Thiagamoorthy, Ilias Giarenis & Linda Cardozo

Pages: 1299-1306

Published online: 14 Aug 2015

AbstractforEarly investigational β3 adreno-receptor agonists for the management of the overactive bladder syndrome | Full Text | References | PDF (224.4 KB)

326 Views
12 CrossRef citations
0Altmetric

An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer

Yeh Chen Lee MBBS BMedSci FRACP, Michael Michael MBBS (Hons) BSc (Hons) MD FRACP & John R Zalcberg OAM MBBS PhD FRACP FRACMA FAHMS FAICD

Pages: 1307-1320

Published online: 27 Jul 2015

AbstractforAn overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer | Full Text | References | PDF (452.9 KB)

322 Views
7 CrossRef citations
0Altmetric

Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development

Anita L Nelson (Professor OB-GYN) MD

Pages: 1321-1330

Published online: 08 Aug 2015

AbstractforInvestigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development | Full Text | References | PDF (267.2 KB)

323 Views
7 CrossRef citations
0Altmetric

Immunotherapies currently in development for the treatment of type 1 diabetes

Ian C Davis, Jacqueline Randell & Stephen N Davis (Dr. Theodore E Woodward Professor and Chair of Medicine) MBBS FACP

Pages: 1331-1341

Published online: 12 Sep 2015

AbstractforImmunotherapies currently in development for the treatment of type 1 diabetes | Full Text | References | PDF (390.8 KB)

639 Views
6 CrossRef citations
0Altmetric

An overview of developing TNF-α targeted therapy for the treatment of psoriasis

Molly Campa MD, Caitriona Ryan MD & Alan Menter MD

Pages: 1343-1354

Published online: 08 Aug 2015

AbstractforAn overview of developing TNF-α targeted therapy for the treatment of psoriasis | Full Text | References | PDF (309.9 KB)

1071 Views
23 CrossRef citations
0Altmetric

Early investigational drugs targeting tau protein for the treatment of Alzheimer’s disease

Keshav Anand MD & Marwan Sabbagh MD FAAN

Pages: 1355-1360

Published online: 01 Aug 2015

AbstractforEarly investigational drugs targeting tau protein for the treatment of Alzheimer’s disease | Full Text | References | PDF (200 KB)

881 Views
27 CrossRef citations
0Altmetric

Novel chemotherapeutics and other therapies for treating high-grade glioma

Jennifer H Kang (Fourth Year Medical Student) BS & Cory Adamson (Associate Professor of Neurosurgery & Neurobiology) (Director, Molecular Neuro-oncology Lab) MD PhD MPH MHS FAANS FACS

Pages: 1361-1379

Published online: 14 Aug 2015

AbstractforNovel chemotherapeutics and other therapies for treating high-grade glioma | Full Text | References | PDF (594.3 KB)

651 Views
21 CrossRef citations
0Altmetric

Drug Evaluation

Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus

Nasser Mikhail (Chief, Endocrinology Division) (Clinical Professor of Medicine) MD MSc

Pages: 1381-1387

Published online: 14 Aug 2015

AbstractforRemogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitus | Full Text | References | PDF (265.4 KB)

527 Views
17 CrossRef citations
0Altmetric

An evaluation of RVX-208 for the treatment of atherosclerosis

Dragana Nikolic, Manfredi Rizzo, Dimitri P Mikhailidis, Norman C Wong & Maciej Banach (Professor, Chair of Nephrology and Hypertension, Head) MD, PhD, FNLA, FAHA, FESC, FASA

Pages: 1389-1398

Published online: 12 Sep 2015

AbstractforAn evaluation of RVX-208 for the treatment of atherosclerosis | Full Text | References | PDF (419.7 KB)

548 Views
25 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.24, Iss.10, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?